Danielle Carrol

Abstract 100: Novel selective PI3Kγ inhibitor AZD3458 promotes anti-tumor immune responses and reverts resistance to immunotherapy in checkpoint blockade refractory preclinical models

S. Barry, Cristina Gardelli, T. Klinowska, 2019, Tumor Biology.